# Dan Patrick Adds Data Centers, Prediction Markets, and THC to Senate Priorities

> **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637)
> **Publisher:** CED Clinic (https://cedclinic.com)
> **Canonical URL:** https://cedclinic.com/texas-senate-data-centers-legislative-priorities-2026/
> **Published:** 2026-03-29T02:03:43-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:35:48-04:00
> **Clinical Summary:** Explore Texas Senate data centers legislative priorities and their impact on cannabis policy and patient access in 2026.

---

✦ New
CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
⚒ Cannabis News  |  CED Clinic
Policy[Medical Cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/)ThcAccessTexas

Why This Matters

Legislative priorities at the state level directly impact patient access to cannabis treatments and physician ability to recommend these therapies. Texas policy decisions influence both intrastate medical cannabis programs and interstate patient mobility for those seeking legal access.

Clinical Summary
Texas Lieutenant Governor Dan Patrick has added THC-related legislation to the Senate’s priority list, though specific details about the scope and direction of proposed changes are not provided in the source material. Texas currently operates a restrictive medical cannabis program limited to low-THC products for specific qualifying conditions. Legislative attention to THC policy could signal potential expansion or restriction of current patient access frameworks.

Dr. Caplan’s Take

“Without knowing whether this represents expansion or restriction, I’m watching for details on qualifying conditions and THC limits—these specifics determine whether Texas patients gain meaningful access or remain in a therapeutic gray zone.”

Clinical Perspective
🧠 Clinicians in Texas should monitor how any THC legislation affects current Compassionate Use Program parameters, particularly THC concentration limits and qualifying condition lists. Patients currently traveling to other states for [cannabis access](https://cedclinic.com/medical-cannabis-delivery-services-growth-dmv-jamaica/) may want to track whether Texas policy changes could provide local alternatives.

💬 Join the Conversation

Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan)

Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/)

Have thoughts on this? Share it:

[𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%2C%20THC%20to%20Senate%20priorities%20%40drcaplan&url=https%3A//sanantonioreport.org/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//sanantonioreport.org/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Dan%20Patrick%20adds%20data%20centers%2C%20prediction%20markets%2C%20THC%20to%20Senate%20priorities%20--%20via%20%40drcaplan.bsky.social%20https%3A//sanantonioreport.org/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/)

📰 Source: [https://sanantonioreport.org/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/](https://sanantonioreport.org/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/)

Table of Contents

- [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis news?](#What_is_the_clinical_relevance_rating_of_this_cannabis_news)
- [What type of cannabis content does this article cover?](#What_type_of_cannabis_content_does_this_article_cover)
- [Why should clinicians pay attention to this information?](#Why_should_clinicians_pay_attention_to_this_information)
- [What areas of medical cannabis does this article address?](#What_areas_of_medical_cannabis_does_this_article_address)
- [How does this fit into current medical cannabis research and policy?](#How_does_this_fit_into_current_medical_cannabis_research_and_policy)
- [Related](#Related)

## FAQ

#### What is the clinical relevance rating of this cannabis news?

This article has been assigned a CED Clinical Relevance rating of #70, indicating “Notable Clinical Interest.” This rating suggests the content contains emerging findings or policy developments that healthcare professionals should monitor closely.

#### What type of cannabis content does this article cover?

Based on the tags, this article focuses on medical cannabis policy developments. It specifically addresses topics related to THC and patient access to medical cannabis treatments.

#### Why should clinicians pay attention to this information?

The “Notable Clinical Interest” designation indicates this contains emerging findings or policy changes that could impact clinical practice. Healthcare providers should monitor these developments as they may affect [patient care](https://cedclinic.com/cannabis-cardiovascular-risk-impact/) and treatment options.

#### What areas of medical cannabis does this article address?

The article covers multiple aspects including medical cannabis policy, THC-related developments, and patient access issues. These interconnected topics are crucial for understanding the current medical cannabis landscape.

#### How does this fit into current medical cannabis research and policy?

This represents part of the evolving medical cannabis policy environment that clinicians need to track. The CED rating system helps prioritize which developments warrant closer attention in clinical practice.

{“@context”: “https://schema.org”, “@type”: “NewsArticle”, “headline”: “Dan Patrick adds data centers, prediction markets, THC to Senate priorities”, “url”: “https://sanantonioreport.org/dan-patrick-adds-data-centers-prediction-markets-and-thc-to-senate-priorities/”, “datePublished”: “2026-03-28T20:21:09Z”, “about”: “dan patrick adds data centers prediction”}

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.

Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance

 [Leave a Message](https://cedclinic.com/contact/)
 [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/)
 [Medical Consulting](https://cedclinic.com/book/)
 [Cannabis Care](https://cedclinic.com/book/)
 

 [https://cedclinic.com/contact/](https://cedclinic.com/contact/)
 

RELATED READING AT CED CLINIC

Continue exploring the evidence

[Dan Patrick adds data centers, prediction markets and THC to Senate priorities – Yahoo](https://cedclinic.com/texas-medical-cannabis-access-barriers-senate-priorities/)

An overview of Texas Senate priorities including data centers and cannabis program challenges.

[Read More](https://cedclinic.com/texas-medical-cannabis-access-barriers-senate-priorities/)

[Dan Patrick Adds Data Centers, Prediction Markets, and THC to Senate Priorities | KVEO-TV](https://cedclinic.com/texas-senate-cannabis-legislative-priorities-update-2026/)

Detailed update on Texas Senate cannabis legislative priorities for 2026 including data centers and THC.

[Explore Details](https://cedclinic.com/texas-senate-cannabis-legislative-priorities-update-2026/)

[Dan Patrick Adds Data Centers, Prediction Markets and THC to Senate Priorities | State](https://cedclinic.com/texas-medical-cannabis-access-barriers-senate-priorities/)

Insights into how Texas Senate priorities affect [medical cannabis access](https://cedclinic.com/medical-marijuana-card-reciprocity/) and data center policies.

[Learn More](https://cedclinic.com/texas-medical-cannabis-access-barriers-senate-priorities/)

 

### Related

---

### Verification & Medical Governance

- **Lead Clinical Author:** Benjamin Caplan, MD
- **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House).
- **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`).
- **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/).
- **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637).
- **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).